Literature DB >> 7586571

Identification of the D-enantiomer of 2-hydroxyglutaric acid in glutaric aciduria type II.

H Watanabe1, S Yamaguchi, K Saiki, N Shimizu, T Fukao, N Kondo, T Orii.   

Abstract

We determined the optical isomer of the 2-hydroxyglutaric acid (2HG) that was elevated in the urine of five Japanese children with a mild form of glutaric aciduria type II (GA2), caused by a deficiency of electron transfer flavoprotein (ETF) or ETF-ubiquinone oxidoreductase (ETF-QO). The D- and L-enantiomers of 2HG were separated by capillary gas chromatography with a combination of (S)-(+)-2-octanol derivatization and chromatography on a DB-1 column. The isomer that was elevated in GA2 patients was predominantly the D-enantiomer, an observation that may serve as an additional marker for the biochemical diagnosis of GA2. D-2HG dehydrogenation, but not L-2HG dehydrogenation is apparently blocked in GA2. A specific D-2HG dehydrogenase or D-2HG-CoA dehydrogenase may be metabolically linked to ETF and ETF-QO in the mitochondria.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7586571     DOI: 10.1016/0009-8981(95)06074-n

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  3 in total

1.  Coupling between d-3-phosphoglycerate dehydrogenase and d-2-hydroxyglutarate dehydrogenase drives bacterial l-serine synthesis.

Authors:  Wen Zhang; Manman Zhang; Chao Gao; Yipeng Zhang; Yongsheng Ge; Shiting Guo; Xiaoting Guo; Zikang Zhou; Qiuyuan Liu; Yingxin Zhang; Cuiqing Ma; Fei Tao; Ping Xu
Journal:  Proc Natl Acad Sci U S A       Date:  2017-08-21       Impact factor: 11.205

2.  D-2-Hydroxyglutaric aciduria in a patient with a severe clinical phenotype and unusual MRI findings.

Authors:  M Wajne; C R Vargas; C Funayama; A Fernandez; M L C Elias; S I Goodman; C Jakobs; M S van der Knaap
Journal:  J Inherit Metab Dis       Date:  2002-02       Impact factor: 4.982

3.  Identification of a dehydrogenase acting on D-2-hydroxyglutarate.

Authors:  Younes Achouri; Gaëtane Noël; Didier Vertommen; Mark H Rider; Maria Veiga-Da-Cunha; Emile Van Schaftingen
Journal:  Biochem J       Date:  2004-07-01       Impact factor: 3.857

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.